• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge.

作者信息

Riesinger L, Wakili R, Dobrev D

机构信息

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Essen, Germany.

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

出版信息

Int J Cardiol Heart Vasc. 2021 Apr 23;34:100785. doi: 10.1016/j.ijcha.2021.100785. eCollection 2021 Jun.

DOI:10.1016/j.ijcha.2021.100785
PMID:33997258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8095112/
Abstract
摘要

相似文献

1
Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge.心房颤动的中风预防：改善当代抗血栓形成方法在不同地区使用不足的情况仍然是一项挑战。
Int J Cardiol Heart Vasc. 2021 Apr 23;34:100785. doi: 10.1016/j.ijcha.2021.100785. eCollection 2021 Jun.
2
Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.一项基于社区的研究中，1985年至1997年房颤患者在卒中发作前抗栓治疗的使用趋势。从科学证据到临床实践。
Prev Med. 2004 Feb;38(2):121-8. doi: 10.1016/j.ypmed.2003.09.002.
3
Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.心房颤动患者预防中风使用抗血栓药物的决策：医疗专业人员的观点
Int J Clin Pharm. 2016 Aug;38(4):985-95. doi: 10.1007/s11096-016-0329-y. Epub 2016 Jun 10.
4
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.心房颤动的二级与一级卒中预防：达灵顿心房颤动注册研究的见解。
Stroke. 2017 Aug;48(8):2198-2205. doi: 10.1161/STROKEAHA.116.016146. Epub 2017 Jul 5.
5
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.出院时房颤患者遵循指南指导的抗栓治疗情况评估。
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):502-508. doi: 10.1177/1074248418778804. Epub 2018 May 27.
6
Implementation of antithrombotic management in atrial fibrillation.心房颤动抗栓治疗的实施
Postgrad Med J. 2000 Dec;76(902):783-6. doi: 10.1136/pmj.76.902.783.
7
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.在未接受充分抗凝治疗的高危房颤患者中可能可预防的中风。
Stroke. 2009 Jan;40(1):235-40. doi: 10.1161/STROKEAHA.108.516344. Epub 2008 Aug 28.
8
Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.左心耳封堵联合 6 周抗栓治疗：前瞻性单中心经验。
Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.
9
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.心房颤动和心房扑动患者的预后和指南一致的抗血栓治疗：真实临床实践中治疗不足和过度治疗的影响；卢瓦尔河谷心房颤动项目。
Chest. 2011 Oct;140(4):911-917. doi: 10.1378/chest.10-2436. Epub 2011 Mar 24.
10
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

引用本文的文献

1
Recent highlights from the on challenges for adequate stroke prevention in patients with atrial fibrillation.关于心房颤动患者充分预防卒中挑战的近期要点。
Int J Cardiol Heart Vasc. 2023 Aug 21;48:101259. doi: 10.1016/j.ijcha.2023.101259. eCollection 2023 Oct.
2
One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study.中东地区心房颤动患者的一年临床结局：约旦心房颤动（JoFib）研究
Int J Vasc Med. 2022 Apr 13;2022:4240999. doi: 10.1155/2022/4240999. eCollection 2022.

本文引用的文献

1
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.勘误：《2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南》：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC的欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Oct 21;42(40):4194. doi: 10.1093/eurheartj/ehab648.
2
Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.非洲/中东地区新诊断房颤患者的抗栓治疗模式及达比加群治疗患者的2年随访结果：GLORIA-AF注册研究项目的II期结果
Int J Cardiol Heart Vasc. 2021 Apr 10;34:100763. doi: 10.1016/j.ijcha.2021.100763. eCollection 2021 Jun.
3
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.心房颤动病理生理学和治疗的分子基础：转化视角。
Circ Res. 2020 Jun 19;127(1):51-72. doi: 10.1161/CIRCRESAHA.120.316363. Epub 2020 Jun 18.
4
Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle.心房颤动管理的区域登记系统：全球难题中的关键部分。
Int J Cardiol Heart Vasc. 2020 Jan 29;26:100473. doi: 10.1016/j.ijcha.2020.100473. eCollection 2020 Feb.
5
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants.直击要害：口服抗凝剂的多效抗心律失常作用。
Pharmacol Res. 2019 Jul;145:104257. doi: 10.1016/j.phrs.2019.104257. Epub 2019 May 2.
6
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.不同临床环境下房颤患者的卒中与死亡 1 年风险：海湾 SAFE 登记研究和达灵顿房颤登记研究。
Int J Cardiol. 2019 Jan 1;274:158-162. doi: 10.1016/j.ijcard.2018.08.091. Epub 2018 Sep 1.
7
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.心房颤动卒中预防的变化格局：GLORIA-AF 注册研究 2 期结果。
J Am Coll Cardiol. 2017 Feb 21;69(7):777-785. doi: 10.1016/j.jacc.2016.11.061.
8
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.欧洲心律协会/美国心律学会/亚太心律学会/拉丁美洲心律学会关于心房心肌病的专家共识：定义、特征及临床意义
Heart Rhythm. 2017 Jan;14(1):e3-e40. doi: 10.1016/j.hrthm.2016.05.028. Epub 2016 Jun 10.
9
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.心房颤动的临床特征和病理生理学：临床特征、流行病学和机制之间的关系。
Circ Res. 2014 Apr 25;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211.
10
Edoxaban versus warfarin in patients with atrial fibrillation.依度沙班与华法林用于房颤患者。
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.